NDC 66689-005-01 - Hydrocodone Bitartrate and Acetaminophen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-005
- Requested NDC
- 66689-005-01
- Package NDCs from labels
- 66689-005-01, 66689-005-50
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocodone Bitartrate and Acetaminophen - VistaPharm, LLC | VistaPharm, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66689-005-50 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0938-111a-e063-dadaa90a10e2 | Hydrocodone Bitartrate and Acetaminophen Oral Solution, CII |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-005-01 | ML - Milliliter | 66689-005 | 0047ce97-2c9b-4817-adc1-22461f69467e | 1 | 2019-07-02 |
| 66689-005-50 | ML - Milliliter | 66689-005 | 3bfc0e60-dde1-4375-abfe-cc156f1aae28 | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cleareyes Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Lil' Drug Store Products, Inc. | 39e4ab2b-ae12-4339-b219-109cf0f7f06a | 2023-12-15 | Warnings | PDC6A3C0OX |
| Pain Reliever | ACETAMINOPHEN TABLET, EXTRA STRENGTH | Lil' Drug Store Products, Inc. | f0fdab5a-9d07-57aa-e053-2a95a90adc7f | 2023-12-15 | Warnings | 362O9ITL9D |
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | PDC6A3C0OX |
| Circle K Pain Reliever Extra Strength | ACETAMINOPHEN | Lil' Drug Store Products, Inc. | f2359bc3-901f-4ecb-b402-cb2fe404a935 | 2023-12-14 | Warnings | 362O9ITL9D |
| Non-Drowsy Sinus Severe, Circle K | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL CAPLET, FILM-COATED | Lil' Drug Store products, Inc. | e78c456f-f62e-596d-e053-2995a90a2397 | 2023-12-14 | Warnings | 362O9ITL9D |
| Non-Drowsy Max Cold | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCI TABLET, FILM-COATED | Lil' Drug Store Products, Inc. | e79f1a92-d8ea-e3f9-e053-2a95a90a2d37 | 2023-12-14 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Novel Laboratories, Inc. | b203c87c-1108-4eaa-8a57-87be776d8a70 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | NO70W886KK |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant | GLYCERIN | L'Oreal USA Products Inc | 32eaaaab-41bd-4efe-a71d-92e3a702c1e5 | 2023-12-11 | Warnings | PDC6A3C0OX |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Childrens Pain Relief | ACETAMINOPHEN | DISCOUNT DRUG MART | c55b8f9d-1396-43c0-acc9-5e3485eadb07 | 2023-12-08 | Warnings | 362O9ITL9D |
| Childrens Pain Relief | ACETAMINOPHEN | DISCOUNT DRUG MART | 775519ad-5683-451f-9bfc-5fafc70c68ec | 2023-12-08 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | WALGREEN CO. | c20c814b-35f5-4c46-e053-2a95a90a50f2 | 2023-12-08 | Warnings | 362O9ITL9D |
| Acetaminophen Extra Strength | ACETAMINOPHEN | Better Living Brands LLC | f9859be4-6d0b-2ab8-e053-6294a90aa862 | 2023-12-06 | Warnings | 362O9ITL9D |
| Aurophen Regular Strength | ACETAMINOPHEN | KROGER COMPANY | b9b7b849-c3b3-9af7-e053-2a95a90a0077 | 2023-12-06 | Warnings | 362O9ITL9D |
| Acetaminophen Regular Strength | ACETAMINOPHEN | KROGER COMPANY | cf649478-57d2-cc88-e053-2a95a90ad1ba | 2023-12-06 | Warnings | 362O9ITL9D |
| Acetaminophen Extra Strength | ACETAMINOPHEN | KROGER COMPANY | b9b6f878-1ec8-3dc0-e053-2995a90a5414 | 2023-12-06 | Warnings | 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | WALGREEN CO. | a48c522c-76c5-49f8-8c4d-3ee6b221e6f3 | 2023-12-06 | Warnings | 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | WALGREEN CO. | cc939a7c-ce56-5dd6-e053-2995a90aa8af | 2023-12-06 | Warnings | 362O9ITL9D |
| Ringl | ACETAMINOPHEN | Sato Pharmaceutical Co., Ltd. | ba5a0286-3e0f-4bef-96e5-29d92f51f432 | 2023-12-06 | Warnings | 362O9ITL9D |
| Childrens Plus Flu | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCI | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 1598e6f8-08ee-4216-a5ab-76cad37b09a7 | 2023-12-06 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.